The procedures have been performed by Sandeep Bagla, interventional radiologist, using the Magellan Robotic System. Bagla is one of the world leaders in the development of prostate artery embolization and is at the forefront of applying the Magellan Robotic System to this expanding procedure.
“We are excited about our clinical experiences with the Magellan Robotic System for prostatic artery embolization,” said Bagla, “Prostate artery embolization is a highly complex procedure that demands precision and control, key elements which are enhanced through robotics. We have completed 30 procedures thus far with the Magellan Robotic System and are delighted with the results we are seeing. We are highly confident in our ability to navigate through tortuous anatomy, our patients are very open to the approach and personally, I am drawn to the ability to reduce my procedural radiation exposure.”
Prostate artery embolization is a novel therapy in which the size of the prostate is reduced by a less invasive catheter-based approach that works to reduce blood flow to the main arteries that feed the prostate. Successfully performed prostatic artery embolization can reduce the prostate gland size and eliminate the symptoms associated with benign prostatic hyperplasia. Currently a patient must choose between long-term medical therapy or highly invasive surgical options that may often result in complications such as pain, bleeding, incontinence or impotence.
The Magellan Robotic System is designed to offer procedural predictability, control, and catheter stability to physicians as they remotely navigate the robotic catheter through the vasculature. Magellan’s remote workstation allows physicians to navigate through the vasculature while seated away from the radiation field, potentially reducing physicians’ radiation exposure and procedural fatigue.